Is the value of urodynamics undermined by poor technique?: ICI-RS 2018.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
12 2019
Historique:
received: 03 12 2018
revised: 18 01 2019
accepted: 04 03 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 20 5 2020
Statut: ppublish

Résumé

The quality of urodynamic measurements in clinical practice has been debated as a matter of concern. It is considered plausible that this has a direct bearing on patient care and the perceived value of urodynamic testing. This is a report of the proceedings of the Think Tank: "Is the value of urodynamics undermined by poor technique?" from the Annual International Consultation on Incontinence-Research Society, which took place in June 2018 in Bristol, UK. The Think Tank discussed the evidence for deficiencies in urodynamic test quality and considered the implications of improvements for clinical diagnosis and practice. There is evidence that technique affects urodynamic quality, and that urodynamic practice is variable. Factors such as team skill set, technologies used, and training received will also affect the quality of urodynamic service. Questions exist regarding the influence of technique on the utility and perceived value of urodynamics. We suggest research questions that will provide the necessary evidence on the link between technique, reporting, and outcome, and clarify the role of good practice in the utility of urodynamic testing.

Identifiants

pubmed: 31821637
doi: 10.1002/nau.23978
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S35-S39

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Andrew Gammie (A)

Southmead Hospital, Bristol, UK.

Fernando Almeida (F)

Universidade Federal de São Paulo, São Paulo, Brazil.

Marcus Drake (M)

Southmead Hospital, Bristol, UK.

Enrico Finazzi Agrò (E)

Tor Vergata University Hospital, Rome, Italy.

Ruth Kirschner-Hermanns (R)

Friedrich Wilhelms University Bonn and Neurological Rehabilitation Centre, Bonn, Germany.

Nucelio Lemos (N)

Mt. Sinai Hospital, Toronto, ON, Canada.

Frank Martens (F)

Radboud University Medical Centre, Nijmegen, The Netherlands.

Ulrich Mehnert (U)

Balgrist Hospital SCI Center, Zürich, Switzerland.

Peter Rosier (P)

UMC Utrecht, Utrecht, The Netherlands.

Francoise Valentini (F)

Université Pierre et Marie Curie, Hôpital Rothschild, Paris, France.

Paul Abrams (P)

Southmead Hospital, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH